$ZPTA
Zapata Computing Holdings Inc.

2023 Q2 Form 10-Q Financial Statement

#000119312523202851 Filed on August 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $1.150M
YoY Change
Gross Profit $282.0K
YoY Change
Gross Profit Margin
Selling, General & Admin $2.947M
YoY Change
% of Gross Profit 1045.04%
Research & Development $1.470M
YoY Change
% of Gross Profit 521.28%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.318M $464.3K
YoY Change 265.98% 32142.36%
Operating Profit -$1.318M
YoY Change 265.97%
Interest Expense $2.851M $1.994M
YoY Change 812.35%
% of Operating Profit
Other Income/Expense, Net $2.851M
YoY Change 812.35%
Pretax Income $1.533M $1.530M
YoY Change -3323.82% -106351.39%
Income Tax $23.00K
% Of Pretax Income 1.5%
Net Earnings $1.533M $1.530M
YoY Change -3323.81% -106351.39%
Net Earnings / Revenue
Basic Earnings Per Share -$1.01
Diluted Earnings Per Share $0.05 $0.05
COMMON SHARES
Basic Shares Outstanding 4.661M
Diluted Shares Outstanding 4.661M

Balance Sheet

Concept 2023 Q2 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $415.9K $616.1K
YoY Change -56.79%
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $371.2K $590.9K
YoY Change -42.33% 28723.41%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $787.1K $1.207M
YoY Change -50.99% 58806.93%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $244.6M $239.1M
YoY Change 3.59%
Other Assets $0.00 $24.47K
YoY Change -100.0% -95.89%
Total Long-Term Assets $244.6M $239.2M
YoY Change 3.45% 40056.92%
TOTAL ASSETS
Total Short-Term Assets $787.1K $1.207M
Total Long-Term Assets $244.6M $239.2M
Total Assets $245.4M $240.4M
YoY Change 3.09% 40121.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $420.2K $30.35K
YoY Change 1827.34%
Deferred Revenue $500.0K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $420.2K $115.3K
YoY Change 293.41% -80.23%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $10.42M $8.210M
YoY Change 29.24%
Total Long-Term Liabilities $10.42M $8.210M
YoY Change 29.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $420.2K $115.3K
Total Long-Term Liabilities $10.42M $8.210M
Total Liabilities $10.84M $8.325M
YoY Change 32.69% 1326.77%
SHAREHOLDERS EQUITY
Retained Earnings -$10.05M -$7.094M
YoY Change 60.98% 65220.42%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$10.05M -$7.094M
YoY Change
Total Liabilities & Shareholders Equity $245.4M $240.4M
YoY Change 3.09% 40121.2%

Cashflow Statement

Concept 2023 Q2 2022 Q4
OPERATING ACTIVITIES
Net Income $1.533M $1.530M
YoY Change -3323.81% -106351.39%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.156M -$191.5K
YoY Change 328.51% 2466.49%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.173M 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -1.156M -191.5K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 1.173M 0.000
Net Change In Cash 17.09K -191.5K
YoY Change -106.33%
FREE CASH FLOW
Cash From Operating Activities -$1.156M -$191.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001843714
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41218
dei Entity Registrant Name
EntityRegistrantName
ANDRETTI ACQUISITION CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1578373
dei Entity Address Address Line1
EntityAddressAddressLine1
7615 Zionsville Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Indianapolis
dei Entity Address State Or Province
EntityAddressStateOrProvince
IN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
46268
dei City Area Code
CityAreaCode
317
dei Local Phone Number
LocalPhoneNumber
872-2700
dei Security12b Title
Security12bTitle
Class A ordinary shares, $0.0001 par value
dei Trading Symbol
TradingSymbol
WNNR
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
wnnr Number Of Days Within Which The Public Shares Shall Be Redeemed
NumberOfDaysWithinWhichThePublicSharesShallBeRedeemed
P10D
CY2023Q2 us-gaap Cash
Cash
415845
CY2022Q4 us-gaap Cash
Cash
616120
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
371233
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
590883
CY2023Q2 us-gaap Assets Current
AssetsCurrent
787078
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1207003
CY2023Q2 wnnr Prepaid Insurance Non Current
PrepaidInsuranceNonCurrent
0
CY2022Q4 wnnr Prepaid Insurance Non Current
PrepaidInsuranceNonCurrent
24469
CY2023Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
244569240
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
239149736
CY2023Q2 us-gaap Assets
Assets
245356318
CY2022Q4 us-gaap Assets
Assets
240381208
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
403024
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
30348
CY2023Q2 wnnr Accrued Interest Payable Related Party Current
AccruedInterestPayableRelatedPartyCurrent
17139
CY2022Q4 wnnr Accrued Interest Payable Related Party Current
AccruedInterestPayableRelatedPartyCurrent
0
CY2023Q2 wnnr Accrued Offering Costs Current
AccruedOfferingCostsCurrent
0
CY2022Q4 wnnr Accrued Offering Costs Current
AccruedOfferingCostsCurrent
85000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
420163
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
115348
CY2023Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1426670
CY2022Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
0
CY2023Q2 wnnr Deferred Legal Fee Non Current
DeferredLegalFeeNonCurrent
940000
CY2022Q4 wnnr Deferred Legal Fee Non Current
DeferredLegalFeeNonCurrent
160000
CY2023Q2 wnnr Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
8050000
CY2022Q4 wnnr Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
8050000
CY2023Q2 us-gaap Liabilities
Liabilities
10836833
CY2022Q4 us-gaap Liabilities
Liabilities
8325348
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
244569240
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
239149736
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10050330
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7094451
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-10049755
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-7093876
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
245356318
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
240381208
CY2023Q2 wnnr Formationprofessional Feesandgeneral And Administrativecosts
FormationprofessionalFeesandgeneralAndAdministrativecosts
1317655
CY2022Q2 wnnr Formationprofessional Feesandgeneral And Administrativecosts
FormationprofessionalFeesandgeneralAndAdministrativecosts
360040
wnnr Formationprofessional Feesandgeneral And Administrativecosts
FormationprofessionalFeesandgeneralAndAdministrativecosts
3586022
wnnr Formationprofessional Feesandgeneral And Administrativecosts
FormationprofessionalFeesandgeneralAndAdministrativecosts
658252
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1317655
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-360040
us-gaap Operating Income Loss
OperatingIncomeLoss
-3586022
us-gaap Operating Income Loss
OperatingIncomeLoss
-658252
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2881840
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
312480
us-gaap Investment Income Interest
InvestmentIncomeInterest
5419504
us-gaap Investment Income Interest
InvestmentIncomeInterest
334239
CY2023Q2 wnnr Change In Fair Value Of Convertible Promissory Notes Related Party
ChangeInFairValueOfConvertiblePromissoryNotesRelatedParty
15381
CY2022Q2 wnnr Change In Fair Value Of Convertible Promissory Notes Related Party
ChangeInFairValueOfConvertiblePromissoryNotesRelatedParty
0
wnnr Change In Fair Value Of Convertible Promissory Notes Related Party
ChangeInFairValueOfConvertiblePromissoryNotesRelatedParty
15989
wnnr Change In Fair Value Of Convertible Promissory Notes Related Party
ChangeInFairValueOfConvertiblePromissoryNotesRelatedParty
0
CY2023Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
15558
CY2022Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
0
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
17139
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
0
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2850901
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
312480
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5386376
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
334239
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1533246
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-47560
us-gaap Net Income Loss
NetIncomeLoss
1800354
us-gaap Net Income Loss
NetIncomeLoss
-324013
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-7093876
CY2023Q1 wnnr Proceeds Receivedin Excess Offair Value Of Convertible Promissory Notes
ProceedsReceivedinExcessOffairValueOfConvertiblePromissoryNotes
288221
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2537664
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
267108
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-9076211
CY2023Q2 wnnr Proceeds Receivedin Excess Offair Value Of Convertible Promissory Notes
ProceedsReceivedinExcessOffairValueOfConvertiblePromissoryNotes
375050
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2881840
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1533246
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-10049755
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
14139
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
13550000
CY2022Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
6440000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10409031
CY2022Q1 wnnr Transaction Costs Allocated To Fair Value Equity Instruments
TransactionCostsAllocatedToFairValueEquityInstruments
-707430
CY2022Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
35290170
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-276453
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-5860883
CY2022Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
334239
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-47560
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-6242682
us-gaap Net Income Loss
NetIncomeLoss
1800354
us-gaap Net Income Loss
NetIncomeLoss
-324013
wnnr Change In Fair Value Of Convertible Promissory Notes Related Party
ChangeInFairValueOfConvertiblePromissoryNotesRelatedParty
15989
wnnr Change In Fair Value Of Convertible Promissory Notes Related Party
ChangeInFairValueOfConvertiblePromissoryNotesRelatedParty
0
us-gaap Investment Income Interest
InvestmentIncomeInterest
5419504
us-gaap Investment Income Interest
InvestmentIncomeInterest
334239
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-219650
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
641671
wnnr Increase Decrease In Prepaid Insurance Non Current
IncreaseDecreaseInPrepaidInsuranceNonCurrent
-24469
wnnr Increase Decrease In Prepaid Insurance Non Current
IncreaseDecreaseInPrepaidInsuranceNonCurrent
318093
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
0
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-10000
wnnr Increase Decrease In Deferred Legal Fee Payable
IncreaseDecreaseInDeferredLegalFeePayable
780000
wnnr Increase Decrease In Deferred Legal Fee Payable
IncreaseDecreaseInDeferredLegalFeePayable
0
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
17139
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
372676
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
21800
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2189227
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1586216
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
0
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
235750000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-235750000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6221
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
225400000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
13550000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
75
wnnr Proceeds From Convertible Promissory Notes Related Party
ProceedsFromConvertiblePromissoryNotesRelatedParty
2073952
wnnr Proceeds From Convertible Promissory Notes Related Party
ProceedsFromConvertiblePromissoryNotesRelatedParty
0
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
240629
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
85000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
417146
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1988952
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
238298521
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-200275
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
962305
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
616120
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
415845
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
962305
wnnr Accretion Of Classa Shares To Redemption Value
AccretionOfClassaSharesToRedemptionValue
5419504
wnnr Accretion Of Classa Shares To Redemption Value
AccretionOfClassaSharesToRedemptionValue
35624409
wnnr Proceeds Received From Convertible Promissory Notesin Excess Ofinitial Fair Value
ProceedsReceivedFromConvertiblePromissoryNotesinExcessOfinitialFairValue
663271
wnnr Proceeds Received From Convertible Promissory Notesin Excess Ofinitial Fair Value
ProceedsReceivedFromConvertiblePromissoryNotesinExcessOfinitialFairValue
0
wnnr Offering Costs Included In Accounts Payable Accrued Expenses
OfferingCostsIncludedInAccountsPayableAccruedExpenses
0
wnnr Offering Costs Included In Accounts Payable Accrued Expenses
OfferingCostsIncludedInAccountsPayableAccruedExpenses
85000
wnnr Fair Value Of Founder Shares In Excess Attributable To Anchor Investor
FairValueOfFounderSharesInExcessAttributableToAnchorInvestor
0
wnnr Fair Value Of Founder Shares In Excess Attributable To Anchor Investor
FairValueOfFounderSharesInExcessAttributableToAnchorInvestor
10402810
wnnr Initial Classification Of Ordinary Shares Subject To Possible Redemption
InitialClassificationOfOrdinarySharesSubjectToPossibleRedemption
0
wnnr Initial Classification Of Ordinary Shares Subject To Possible Redemption
InitialClassificationOfOrdinarySharesSubjectToPossibleRedemption
235750000
wnnr Deferred Under Writing Fees Payable
DeferredUnderWritingFeesPayable
0
wnnr Deferred Under Writing Fees Payable
DeferredUnderWritingFeesPayable
8050000
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-01-20
CY2023Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.25
CY2023Q2 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
CY2023Q2 wnnr Percentage Of Public Shares That Can Be Transferred Without Any Restriction
PercentageOfPublicSharesThatCanBeTransferredWithoutAnyRestriction
0.15
CY2023Q2 wnnr Percentage Of Public Shares To Be Redeemed In Case Business Combination Is Not Consummated
PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated
1
wnnr Period From The Closing Of The Initial Public Offering Within Which Business Combination Shall Be Completed
PeriodFromTheClosingOfTheInitialPublicOfferingWithinWhichBusinessCombinationShallBeCompleted
P18M
CY2023Q2 wnnr Percentage Of Public Shares To Be Redeemed In Case Business Combination Is Not Consummated
PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated
1
CY2023Q2 us-gaap Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities
LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities
100000
CY2023Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
10.25
CY2023Q2 us-gaap Cash
Cash
415845
CY2023Q2 wnnr Working Capital
WorkingCapital
366915
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div></div> </div>
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
wnnr Period To Exercise Warrants After Business Combination
PeriodToExerciseWarrantsAfterBusinessCombination
P30D
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. The Company had not experienced losses on this account. </div>
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
240629
CY2023Q2 wnnr Cummulative Cash Advanced
CummulativeCashAdvanced
2073952
CY2023Q2 wnnr Deferred Underwriting Commission Payable Per Share
DeferredUnderwritingCommissionPayablePerShare
0.35
CY2023Q2 wnnr Deferred Underwriting Commission Payable Current
DeferredUnderwritingCommissionPayableCurrent
8050000
CY2023Q2 wnnr Deferred Legal Fee Non Current
DeferredLegalFeeNonCurrent
940000
CY2022Q4 wnnr Deferred Legal Fee Non Current
DeferredLegalFeeNonCurrent
160000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0

Files In Submission

Name View Source Status
0001193125-23-202851-index-headers.html Edgar Link pending
0001193125-23-202851-index.html Edgar Link pending
0001193125-23-202851.txt Edgar Link pending
0001193125-23-202851-xbrl.zip Edgar Link pending
d502153d10q.htm Edgar Link pending
d502153dex311.htm Edgar Link pending
d502153dex312.htm Edgar Link pending
d502153dex321.htm Edgar Link pending
d502153dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
d502153d10q_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wnnr-20230630.xsd Edgar Link pending
wnnr-20230630_def.xml Edgar Link unprocessable
wnnr-20230630_lab.xml Edgar Link unprocessable
wnnr-20230630_pre.xml Edgar Link unprocessable
wnnr-20230630_cal.xml Edgar Link unprocessable